Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

The Real Obesity Drugs Hurdle: Paying for Them

Jan 19 2012

• By Ramsey Baghdadi

Related Content

Limiting Cost-sharing on Drugs: A Big PhRMA Objective from Health Reform

Aug 01 2009

Weighing the Regulatory Climate: Qnexa and the New Approval Model

Sep 01 2010

Weighing the Risks: Vivus View of Regulatory Risks in <em>Qnexa</em> Reprise

Nov 20 2011

Related Companies

Vivus, Inc.

Arena Pharmaceuticals, Inc.

Orexigen Therapeutics, Inc.

Takeda Pharmaceutical Co. Ltd.

Eisai Co., Ltd.

Additional Topics

Medicaid BioPharmaceutical

More from Medicaid

More from Government Payers

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window